Clinical Trials on Lysinuric Protein Intolerance in Australia

Total 409 results

Medical University of Graz

Completed

Telmisartan and Losartan in Hypertensive IGT

Hypertension | Impaired Glucose Tolerance

Austria
Marcus Saemann

Completed

Glucose Control in Pre-Diabetic Renal Transplant Patients (GCPD)

Kidney Transplantation | Impaired Glucose Tolerance

Austria
Takeda
Theravance Biopharma

Completed

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Enteral Feeding Intolerance

Australia
Sciotec Diagnostic Technologies GmbH

Completed

Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity

Food Intolerance | Histamine Intolerance

Austria
IPSC AG
Medical University of Graz; Sciotec Diagnostic Technologies GmbH

Completed

A Provocation Study Using Biogenic Amines to Show the Efficacy of Oral Diamine Oxidase Supplementation

Histamine Intolerance

Austria
Cerevance

Completed

Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers

Tolerance | Safety Issues

Australia
Medical University of Vienna

Unknown

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (RISC_7T)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric Hypercalcemia

Austria
Western Sydney Local Health District

Recruiting

Improving KIdney Transplantation With Cellular Therapy Study (i-KITCaT)

Kidney Transplant Rejection | Immune Tolerance

Australia
Medical University of Vienna

Completed

Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus

Insulin Sensitivity | Diabetes, Gestational | PreTerm Birth | Glucose Intolerance During Pregnancy | Glucocorticoids

Austria
Novartis

Completed

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Type 2 Diabetes Mellitus | Impaired Glucose Tolerance

United States, Canada, Finland, Australia, Germany, India, Italy
Medical University of Vienna
BIOGENA GmbH

Recruiting

The Effects of Dietary Supplements on Glycemic Control, Body Composition and Hepatic Fat Content in People With Prediabetes

PreDiabetes

Austria
Medical University of Graz

Completed

Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT

Immune Tolerance

Austria
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
Garvan Institute of Medical Research
Weizmann Institute of Science

Active, not recruiting

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes (PREDICT)

Type 2 Diabetes Mellitus | Pre Diabetes

Australia
University of Sydney

Active, not recruiting

Sub-Study of the PREVIEW Study Australia

Obesity | Pre-diabetes

Australia
Monash University

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (RATIONALISE)

Hypogammaglobulinemia | Haematological Malignancy

Australia
Sciotec Diagnostic Technologies GmbH

Not yet recruiting

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Fructose Intolerance

Austria
Millennium Pharmaceuticals, Inc.

Terminated

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Critical Illness | Enteral Nutrition | Enteral Feeding Intolerance

United States, Canada, Australia, United Kingdom
Bayside Health

Terminated

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Royal Brisbane and Women's Hospital

Completed

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Parkinson's Disease | Multiple System Atrophy | Orthostatic Hypotension

Australia
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Spain, Australia, Denmark, Norway
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
Cancer Trials Australia
Human Genome Sciences Inc.

Unknown

A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Symptomatic Waldenstroms Macroglobulinaemia

Australia
AbbVie

Withdrawn

A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Multiple Myeloma

Australia
Gilead Sciences

Terminated

Efficacy Study of CYT997 in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma

Australia
Bayer

Terminated

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Hemophilia A and B

Australia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
Peter MacCallum Cancer Centre, Australia
Janssen-Cilag Ltd.

Completed

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

Multiple Myeloma

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Sciotec Diagnostic Technologies GmbH
Austrian Research Promotion Agency

Completed

Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption

Fructose Malabsorption

Austria
Peter MacCallum Cancer Centre, Australia

Completed

Panobinostat Biological Correlates Study (VEG VCA1)

Multiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With Lymphoma

Australia
Medical University of Vienna

Completed

Glucose Metabolism in Different PCOS Phenotypes

Glucose Metabolism Disorders | Polycystic Ovary Syndrome | Liver Fat | Glucose Intolerance

Austria
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B (DYNAMO)

Hemophilia

Netherlands, Austria, Australia, Belgium, Canada, Finland, Germany, Italy, Spain, United Kingdom
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Shanghai EpimAb Biotherapeutics Co., Ltd.

Recruiting

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Relapsed or Refractory Multiple Myeloma

China, Australia
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Celgene

Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Melanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung Cancer

Australia
Alexandra Kautzky-Willer
Bayer

Recruiting

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism (Test2Func)

Fatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes Mellitus

Austria
Medical University of Vienna

Completed

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

Hemophilia A

Austria
Peter MacCallum Cancer Centre, Australia

Unknown

Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Multiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid Leukaemia

Australia
GlaxoSmithKline

Terminated

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

Relapsed/Refractory Multiple Myeloma

Australia, Sweden, Canada
FH Campus Wien, University of Applied Sciences
Medical University of Vienna; Shire

Completed

Gait Examination in Patients With Hemophilia in Austria (JOSEPHA)

Hemophilia

Austria
Medical University of Graz

Completed

Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors

Patients on Long-term Proton Pump Inhibitor Therapy

Austria

Clinical Trials on Lysinuric Protein Intolerance in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations